Evidence map›Paper›PMID 8985329›Full record

ArticleJournal of virology1997

Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms.

J K Olson, G A Bishop, C Grose

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. The Structures and Functions of VZV Glycoproteins.Current topics in microbiology and immunology · 2023
    Article
  6. Review
  7. Frontiers in microbiology · 2022
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

J K OlsonDepartment of Microbiology and Immunology Program, University of Iowa College of Medicine, Iowa City 52242, USA.
G A Bishop
C Grose
University of Iowa · US

Funding

The Roles of TRAF3 in Lymphocyte SignalingR01AI028847 · NIAID · UNIVERSITY OF IOWA · PI BISHOP, GAIL A. · 1996 to 2011
$3.1M
ANTIGENIC DETERMINANTS OF VARICELLA VIRUSR01AI022795 · NIAID · UNIVERSITY OF IOWA · PI GROSE, CHARLES F. · 1985 to 2006
$2.4M
Understanding TRAF3-mediated regulation of T lymphocyte functionsR56AI028847 · NIAID · UNIVERSITY OF IOWA · PI BISHOP, GAIL A. · 2013 to 2013
$227k
REGULATION OF CLASS II--MEDIATED B CELL DIFFERENTIATIONR29AI028847 · NIAID · UNIVERSITY OF IOWA · PI BISHOP, GAIL A. · 1990 to 1994
–
NIAID NIH HHS AI22795NIAID NIH HHS AI28847
6 · The paper itself

Abstract

Varicella-zoster virus (VZV) glycoprotein gE is the predominant viral cell surface molecule; it behaves as an Fc receptor for immunoglobulin G, but its central function may be more closely related to viral egress and cell-to-cell spread. To further analyze the receptor properties of VZV gE, the gE gene (also called open reading frame 68) was expressed by a baculovirus vector in insect cells. The recombinant baculovirus gE product had a molecular mass of 64 kDa, smaller than the previously documented 98 kDa of mature gE expressed in mammalian cells. The major reason for the lowered molecular mass was diminished glycosylation. In addition to the 64-kDa form, a larger (130-kDa) form was observed in insect cells and represented dimerized 64-kDa molecules. Both the monomeric and dimeric gE forms were highly phosphorylated in insect cells. Protein kinase assays conducted in vitro with [gamma-32P]ATP and [gamma-32P]GTP indicated that endogenous casein kinase II was phosphorylating monomeric gE, while the dimeric gE form was phosphorylated by another kinase which did not utilize [gamma-32P]GTP. When immobilized recombinant gE molecules were probed with a monoclonal antibody which specifically recognizes a phosphotyrosine linkage, the gE dimer was found to be tyrosine phosphorylated whereas the monomer was not similarly modified. When recombinant gE produced in HeLa cells was probed with the same antiphosphotyrosine antibody, a dimeric gE form at 130 kDa was detected on the cell surface. These results suggested that VZV gE closely resembled other cell surface receptors, being modified on its various forms by both serine/threonine and tyrosine protein kinases. In this case, tyrosine phosphorylation occurred on a previously unrecognized and underglycosylated VZV gE dimeric product.

Indexed as

SerineThreonineTyrosineAnimalsBinding SitesCasein Kinase IICell LineConsensus SequenceDimerizationGene ExpressionGlycosylationHeLa CellsHerpesvirus 3, HumanHumansPhosphorylationProtein Serine-Threonine KinasesCasein Kinase IIglycoprotein E, varicella-zoster virusimmunoglobulin M receptorProtein Serine-Threonine KinasesReceptors, FcRecombinant Fusion ProteinsSerineThreonineTyrosineViral Envelope Proteins

Identifiers

PMID8985329
PMCPMC191030
OpenAlexW1526009533

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.